Research Article
Network Pharmacology-Based Study on the Mechanism of Bushen-Jianpi Decoction in Liver Cancer Treatment
Table 1
Univariate analysis of 71 patients with hepatic carcinoma.
| Characteristics | Univariate analysis | N (%) | P-value |
| Gender | | 0.931 | male | 63 (88.7) | | female | 8 (11.3) | | Age | | 0.479 | ≥50 | 47 (66.2) | | < 50 | 24 (33.8) | | Clinical stage composition | | 0.023 | I-III | 31 (43.7) | | IV | 40 (56.3) | | Serum IL10 levels | | 0.916 | > 23.35 pg/mL | 43 (60.6) | | < 23.35 pg/mL | 18 (25.4) | | Serum IL12-P40 levels | | 0.345 | > 200 ng/L | 63 (88.7) | | < 200 ng/L | 8 (11.3) | | Serum IFN-γ levels | | 0.285 | > 15 μg/L | 53 (74.6) | | < 15 μg/L | 18 (25.4) | | BSJPD | | 0.006 | yes | 35 (49.3) | | no | 36 (50.7) | |
|
|
Notes. BSJPD, Bushen-Jianpi decoction; IL, interleukin; IFN-γ, interferon-γ; TACE, transcatheter arterial chemoembolization.
|